financetom
Business
financetom
/
Business
/
Ameren misses fourth-quarter profit estimates on higher interest and operating expenses
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Ameren misses fourth-quarter profit estimates on higher interest and operating expenses
Feb 13, 2025 2:45 PM

Feb 13 (Reuters) - Utility firm Ameren ( AEE ) missed Wall Street estimates for

fourth-quarter profit on Thursday, hurt by higher interest and operating expenses.

The Ameren Missouri unit has been investing heavily in its grid infrastructure upgrades,

increasing borrowings and, in turn, also augmenting its interest expenses.

The St. Louis, Missouri-based company's quarterly interest expenses were up about 12% at

$171 million from a year earlier.

The company's operating expenses for the quarter ended December 31 were also up about 29% at

$1.74 billion from a year earlier, further dragging its earnings.

Ameren ( AEE ) serves about 2.4 million electric customers and more than 900,000 natural gas

customers in Missouri and Illinois.

The company reaffirmed its 2025 earnings forecast range of $4.85 to $5.05 per share.

The utility firm reported an adjusted profit of 77 cents per share in the quarter, missing

Wall Street estimates of 79 cents per share.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Harmony Biosciences to Submit NDA for Narcolepsy Treatment Following Trial Results
Harmony Biosciences to Submit NDA for Narcolepsy Treatment Following Trial Results
Nov 24, 2025
09:08 AM EST, 11/24/2025 (MT Newswires) -- Harmony Biosciences ( HRMY ) said Monday that it expects to submit a New Drug Application to the US Food and Drug Administration in early 2026 for gastro-resistant Wakix (pitolisant GR) to treat narcolepsy. The pharmaceutical company said the evaluation is based on a pivotal bioequivalence study, which it said confirmed that the...
GE HealthCare Submits FDA Application for Photonova Spectra Imaging System
GE HealthCare Submits FDA Application for Photonova Spectra Imaging System
Nov 24, 2025
09:07 AM EST, 11/24/2025 (MT Newswires) -- GE HealthCare Technologies ( GEHC ) said Monday it has submitted a 510(k) application to the US Food and Drug Administration for Photonova Spectra, a photon-counting computed tomography system. A 510(k) is a premarket notification submitted to the FDA to show that a new medical device is substantially equivalent to a legally marketed...
Carvana Likely to Achieve 'Leading' Market Position by Unit Volume in 2026, Wedbush Says
Carvana Likely to Achieve 'Leading' Market Position by Unit Volume in 2026, Wedbush Says
Nov 24, 2025
09:07 AM EST, 11/24/2025 (MT Newswires) -- Carvana ( CVNA ) is likely to reach a leading market position by unit volume in the fourth quarter of next year after delivering strong growth for several quarters, Wedbush Securities said in a Monday client note. The online used car retailer is seeing a favorable shift in momentum in recent weeks and...
BRIEF-Syngenta Is Said To Consider Hong Kong IPO  - Bloomberg News
BRIEF-Syngenta Is Said To Consider Hong Kong IPO - Bloomberg News
Nov 24, 2025
Nov 24 (Reuters) - * SYNGENTA IS SAID TO CONSIDER HONG KONG IPO - BLOOMBERG NEWS Source text: https://tinyurl.com/5eye6yjk ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved